INFR yields 2.49% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, INFR + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INFR + PFE for your $10,000?
INFR invests in equity securities from the infrastructure industry that meet sustainability and financial criteria. Infrastructure companies considered could be of any size with attractive valuations, distributions, and cash flow characteristics, stretching across multiple sub-industries, including oil and gas storage/transportation, gas utilities, and airport services (excluding air navigation service providers). The proprietary methodology applies inclusionary liquidity, exposure, quality, and income screens that evaluates ownership of physical assets, nature of services, monopoly characteristics, and contractual and/or regulatory rights. Qualified companies are assigned a rating across a five-year horizon that assesses their ESG focus, integration, and efforts, specifically climate-related risks and opportunities. The fund may invest up to 20% of its assets in non-US companies. As an actively managed fund, the portfolio managers have full discretion with investments.
Full INFR Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.